Association of cardiac reverse remodeling with prognosis after transcatheter aortic valve replacement in patients with mixed aortic valve disease
摘要
Mixed aortic valve disease (MAVD), characterized by concurrent presence of aortic stenosis (AS) and aortic regurgitation (AR), exhibits distinct cardiac structural and functional characteristics compared to isolated aortic valve disease. The aim of the present study was to elucidate the impact of cardiac reverse remodeling after transcatheter aortic valve replacement (TAVR) on prognosis in MAVD.
MethodsThe present study included patients with severe symptomatic AS and moderate or greater AR who underwent TAVR and both preoperative and one-year follow-up echocardiography. Reverse remodeling after TAVR was defined as the change of each left ventricular end-systolic volume index (LVESVi), end-diastolic volume index or mass index from baseline to one-year follow-up. The primary outcome was a composite of cardiac death and hospitalization due to heart failure. Internal validation was performed bootstrap resampling methods.
ResultsA total of 143 patients was enrolled (83.4 ± 6.0 years, 46.9% male). During a median follow-up period of 519 days, 17 patients achieved the primary outcome. Decrease of LVESVi with a cut-off value of 36% was optimal at identifying favorable prognosis (area under the curve: 0.65, sensitivity: 35%, specificity:100%, P = 0.045). Patients with ≥ 36% reduction of LVESVi after TAVR had significantly better prognosis than those without it (P = 0.004). Preoperative larger LVESVi and higher LV mass index were predictors of ≥ 36% decrease of LVESVi following TAVR.
ConclusionGreater decrease of LVESVi following TAVR was associated with improved postoperative prognosis in MAVD. Patients with more advanced preoperative cardiac remodeling exhibited greater postoperative reverse remodeling.